SLU-PP-332
Selleck Chemicals
SKU:E1903-5MG
Couldn't load pickup availability

SLU-PP-332 is an agonist of ERRbeta and ERRgamma and related targets used in studies of Hormone Signaling. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to ligand-dependent transcriptional programs and endocrine regulation in cancer and endocrinology models.
By activating ERRbeta and ERRgamma and related targets, SLU-PP-332 can be used to examine ligand-dependent transcriptional programs and endocrine regulation. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In cancer and endocrinology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving ERRbeta and ERRgamma and related targets
- Pathway perturbation studies connected to Hormone Signaling
- Agonist-response and downstream signaling studies
- Reporter-gene, receptor-binding, and transcriptional assays
Overall, SLU-PP-332 is appropriate when a defined chemical perturbant is needed to connect ERRbeta and ERRgamma and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer and endocrinology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- ERRbeta • ERRgamma • Estrogen Receptor
- Target Class:
- Nuclear Receptor
- Pathways:
- Hormone Signaling
- Research Area:
- Cancer • Endocrinology
- CAS No.:
- 303760-60-3
- Molecular Weight:
- 290.32
- Formula:
- C₁₈H₁₄N₂O₂
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.